UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$190M |
| 2 |
Honeywell
HON
|
+$189M |
| 3 |
Oracle
ORCL
|
+$149M |
| 4 |
JPMorgan Chase
JPM
|
+$125M |
| 5 |
Alibaba
BABA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$193M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$158M |
| 3 |
Allstate
ALL
|
+$122M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$108M |
| 5 |
General Dynamics
GD
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.94% |
| 2 | Financials | 15.35% |
| 3 | Healthcare | 13.71% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Five Below
FIVE
$12B
| $1.82M | ﹤0.01% |
33,146
-181,170
| -85% | -$8.87M |
|
|
ILG
1402
DELISTED
ILG, Inc Common Stock
ILG
| $1.81M | ﹤0.01% |
67,818
+1,347
| +2% | +$35.6K |
|
1403
Harmony Gold Mining
HMY
$10.3B
| $1.81M | ﹤0.01% |
989,478
+476,047
| +93% | +$873K |
|
1404
Neogen
NEOG
$2.59B
| $1.81M | ﹤0.01% |
62,181
+4,464
| +8% | +$115K |
|
|
BRFS
1405
DELISTED
BRF SA
BRFS
| $1.8M | ﹤0.01% |
124,900
+800
| +0.6% | +$10.4K |
|
|
AXE
1406
DELISTED
Anixter International Inc
AXE
| $1.79M | ﹤0.01% |
21,111
+778
| +4% | +$59.8K |
|
|
SEM
1407
DELISTED
Select Medical
SEM
| $1.79M | ﹤0.01% |
173,401
+6,385
| +4% | +$59K |
|
|
JNCE
1408
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.79M | ﹤0.01% |
114,972
| – | – |
|
|
ZEN
1409
DELISTED
ZENDESK INC
ZEN
| $1.79M | ﹤0.01% |
61,497
+8,706
| +16% | +$244K |
|
1410
Kemper
KMPR
$1.72B
| $1.79M | ﹤0.01% |
33,718
+2,476
| +8% | +$113K |
|
|
NGD
1411
DELISTED
New Gold Inc
NGD
| $1.78M | ﹤0.01% |
481,742
| – | – |
|
1412
NETSCOUT
NTCT
$2.98B
| $1.78M | ﹤0.01% |
55,065
+2,546
| +5% | +$84.9K |
|
1413
American States Water
AWR
$3.32B
| $1.77M | ﹤0.01% |
35,872
+1,702
| +5% | +$84K |
|
|
LNCE
1414
DELISTED
Snyders-Lance, Inc.
LNCE
| $1.76M | ﹤0.01% |
46,149
+1,796
| +4% | +$64.8K |
|
1415
Saic
SAIC
$5.08B
| $1.75M | ﹤0.01% |
26,217
+1,810
| +7% | +$126K |
|
1416
Northwest Natural Holdings
NWN
$2.06B
| $1.75M | ﹤0.01% |
27,175
+1,371
| +5% | +$88K |
|
1417
Chemed
CHE
$7.07B
| $1.75M | ﹤0.01% |
8,658
+98
| +1% | +$19.3K |
|
1418
Myriad Genetics
MYGN
$289M
| $1.75M | ﹤0.01% |
48,339
+3,430
| +8% | +$97.8K |
|
1419
iShares Russell Mid-Cap ETF
IWR
$56.3B
| $1.75M | ﹤0.01% |
35,416
+652
| +2% | +$31.5K |
|
|
ESL
1420
DELISTED
Esterline Technologies
ESL
| $1.74M | ﹤0.01% |
19,346
-515
| -3% | -$46.4K |
|
1421
Commercial Metals
CMC
$7.77B
| $1.74M | ﹤0.01% |
91,457
+14,440
| +19% | +$271K |
|
1422
Vistra
VST
$52.6B
| $1.73M | ﹤0.01% |
92,660
+48,834
| +111% | +$842K |
|
|
MTOR
1423
DELISTED
MERITOR, Inc.
MTOR
| $1.72M | ﹤0.01% |
66,108
+6,752
| +11% | +$134K |
|
|
MDRX
1424
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.72M | ﹤0.01% |
120,802
+10,521
| +10% | +$136K |
|
1425
iShares 1-3 Year Treasury Bond ETF
SHY
$25B
| $1.71M | ﹤0.01% |
+20,260
| New | +$1.71M |
|
Similar funds
UBS AM's Q3 2017 Portfolio in Review
As of Q3 2017, UBS AM held 2,601 positions worth $110B, up 6.2% from $103B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS AM's Q3 2017 filing shows 79 new, 1,541 increased, 476 reduced and 68 closed positions. Its largest new stake was Ingersoll Rand: 2,780,577 shares worth $76.5M. The largest sale was Du Pont De Nemours E I, an estimated $193M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2017 buy was Ingersoll Rand: 2,780,577 shares worth $76.5M.
- UBS AM added most to DuPont de Nemours in Q3 2017, an estimated $190M increase.
- UBS AM's biggest Q3 2017 reduction was Allstate, cutting an estimated $122M.
- UBS AM fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $193M.
- UBS AM's ten largest holdings make up 16% of its $110B portfolio in Q3 2017.
- UBS AM opened 79 new positions and closed 68 in Q3 2017.
- UBS AM's portfolio value rose 6.2% quarter-over-quarter to $110B.
Based on UBS AM's 13F filing for Q3 2017, filed 13 Nov 2017.